|
|
| | Benzoic acid, 2-[[[3-[(4-cyano-1-naphthalenyl)amino]-4-pyridinyl]thio]methyl]-, sodium salt (1:1) Basic information |
| | Benzoic acid, 2-[[[3-[(4-cyano-1-naphthalenyl)amino]-4-pyridinyl]thio]methyl]-, sodium salt (1:1) Chemical Properties |
| form | Solid | | color | Light yellow to light brown |
| | Benzoic acid, 2-[[[3-[(4-cyano-1-naphthalenyl)amino]-4-pyridinyl]thio]methyl]-, sodium salt (1:1) Usage And Synthesis |
| Uses | KPH2f is a safe, orally active, and effective dual URAT1/GLUT9 inhibitor with IC50s of 0.24 μM and 9.37 μM for URAT1 and GLUT9, respectively. KPH2f shows little effects on OAT1 and ABCG2 (IC50=32.14 and 26.74 μM)[1]. |
| | Benzoic acid, 2-[[[3-[(4-cyano-1-naphthalenyl)amino]-4-pyridinyl]thio]methyl]-, sodium salt (1:1) Preparation Products And Raw materials |
|